Saturday 17 October 2026
Export AMN’s income statement to Excel — free account
AMN Healthcare Services Inc
AMN Healthcare Medical Care Facilities
AMN Healthcare Services Inc’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 8.49% from fiscal 2024. In the quarter to June 2026, revenue grew 2.29%, EPS grew 117.9%, free cash flow fell 389.4% and total debt fell 18.9%, each against the same quarter a year earlier.
40.49
0.49
+1.23%
Follow AMN
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
17.74 | 17.91 | 18.95 | 25.54 | 45.81 | 17.83 | 10.72 | 14.58 | 0.00 | 0.00 |
Piotroski F-Score |
5 | 7 | 5 | 5 | 3 | 6 | 7 | 6 | 4 | 5 |
Altman Z-Score |
3.82 | 4.55 | 4.17 | 3.32 | 2.83 | 4.05 | 4.75 | 3.29 | 2.20 | 2.26 |
P/S ratio |
0.99 | 1.19 | 1.26 | 1.31 | 1.35 | 1.46 | 0.90 | 0.80 | 0.31 | 0.22 |
P/FCF ratio |
16.79 | 17.70 | 13.99 | 15.45 | 14.87 | 23.18 | 8.25 | 11.55 | 3.91 | 2.62 |
Altman Z″-Score (non-manufacturers) |
2.72 | 3.46 | 3.09 | 2.56 | 1.95 | 3.27 | 4.04 | 3.23 | 2.04 | 2.07 |
Beneish M-Score |
(2.40) | (2.53) | (2.69) | (2.75) | (2.79) | (1.60) | (2.79) | (2.91) | (3.68) | (3.39) |
P/Operating CF |
38.29 | 40.59 | 45.53 | 37.00 | 81.23 | 74.80 | 40.98 | (73.76) | 12.55 | 8.03 |
P/B ratio |
4.18 | 4.22 | 4.20 | 3.95 | 3.95 | 5.02 | 4.53 | 3.65 | 1.29 | 0.95 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.17 | 1.35 | 1.46 | 1.55 | 1.70 | 1.63 | 1.05 | 1.14 | 0.66 | 0.49 |
EV/EBITDA |
10.07 | 10.94 | 12.76 | 14.65 | 16.71 | 11.17 | 7.02 | 8.62 | 6.67 | 6.36 |
EV/Operating CF |
16.64 | 16.67 | 13.70 | 15.32 | 15.83 | 21.27 | 8.42 | 11.57 | 6.11 | 4.97 |
EV/FCF |
19.90 | 19.97 | 16.22 | 18.28 | 18.67 | 25.80 | 9.61 | 16.39 | 8.38 | 5.77 |
Quick Ratio |
1.46 | 1.53 | 1.40 | 1.34 | 1.13 | 1.25 | 1.18 | 1.18 | 0.95 | 0.80 |
Current Ratio |
1.64 | 1.79 | 1.57 | 1.48 | 1.26 | 1.39 | 1.27 | 1.28 | 1.09 | 0.94 |
Net Debt/EBITDA |
1.58 | 1.25 | 1.75 | 2.27 | 3.41 | 1.14 | 0.99 | 2.55 | 3.56 | 3.48 |
Debt/Assets |
30.26% | 25.51% | 29.52% | 31.95% | 36.45% | 26.89% | 29.20% | 44.61% | 43.71% | 36.63% |
Debt/Equity |
0.80 | 0.57 | 0.69 | 0.84 | 1.05 | 0.72 | 0.81 | 1.57 | 1.49 | 1.19 |
Asset Turnover |
1.84 | 1.63 | 1.56 | 1.30 | 1.12 | 1.45 | 1.74 | 1.30 | 1.12 | 1.21 |
Operating CF/Net income |
1.27 | 1.21 | 1.60 | 1.97 | 3.63 | 0.93 | 1.47 | 1.77 | (2.18) | (2.82) |
Capex/Depreciation |
(0.74) | (0.83) | (0.89) | (0.63) | (0.42) | (0.52) | (0.59) | (0.65) | (0.20) | (0.13) |
Interest Coverage |
12.39 | 10.80 | 12.56 | 6.22 | 2.59 | 14.03 | 16.02 | 6.25 | (1.47) | (1.22) |
| 26.55% | 26.20% | 23.59% | 16.57% | 9.08% | 33.04% | 40.26% | 22.47% | (19.11%) | (14.19%) | |
| 10.24% | 10.86% | 10.32% | 6.66% | 3.30% | 11.94% | 14.75% | 7.25% | (5.50%) | (4.24%) | |
ROIC |
15.01% | 15.31% | 11.89% | 8.70% | 5.66% | 16.38% | 22.19% | 10.06% | (3.66%) | (2.52%) |
Return on Tangible Assets |
44.89% | 46.95% | 53.42% | 39.69% | 31.14% | 64.60% | 115.34% | 55.89% | (62.44%) | (91.91%) |
Average Days of Receivables |
75.07 | 71.87 | 71.09 | 69.88 | 68.63 | 94.25 | 65.74 | 71.40 | 62.18 | 57.56 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
20.95% | 20.10% | 21.18% | 22.86% | 22.97% | 18.33% | 17.86% | 19.75% | 21.20% | 21.72% |
Intangible Assets out of Total Assets |
0.50 | 0.45 | 0.51 | 0.51 | 0.61 | 0.45 | 0.49 | 0.54 | 0.53 | 0.50 |
Share Based Compensation of Revenue |
0.60% | 0.51% | 0.51% | 0.73% | 0.85% | 0.63% | 0.57% | 0.48% | 0.78% | 1.12% |
Graham Net Nets |
(0.15) | (0.09) | (0.14) | (0.22) | (0.31) | (0.11) | (0.16) | (0.41) | (1.22) | (1.49) |
Graham Number |
21.59 | 27.08 | 30.12 | 29.43 | 24.07 | 61.33 | 72.17 | 50.35 | 0.00 | 0.00 |
Earnings Yield |
5.64% | 5.58% | 5.28% | 3.92% | 2.18% | 5.61% | 9.33% | 6.86% | (16.05%) | (15.80%) |
Free Cash Flow Yield |
5.96% | 5.65% | 7.15% | 6.47% | 6.73% | 4.31% | 12.12% | 8.66% | 25.59% | 38.24% |
Revenue per Share |
39.67 | 41.59 | 45.09 | 47.58 | 50.47 | 83.55 | 117.59 | 96.73 | 78.13 | 70.88 |
Operating CF per Share |
2.79 | 3.36 | 4.79 | 4.81 | 5.42 | 6.40 | 14.66 | 9.50 | 8.39 | 7.00 |
Capex per Share |
(0.46) | (0.55) | (0.77) | (0.78) | (0.82) | (1.13) | (1.81) | (2.69) | (2.12) | (0.92) |
Free Cash Flow per Share |
2.34 | 2.80 | 4.02 | 4.03 | 4.59 | 5.28 | 12.85 | 6.81 | 6.27 | 6.07 |
Cash per Share |
0.22 | 0.32 | 0.29 | 1.78 | 0.62 | 3.79 | 1.45 | 0.84 | 0.28 | 0.88 |
Shareholders Equity per Share |
9.37 | 11.77 | 13.49 | 15.77 | 17.28 | 24.37 | 23.40 | 21.22 | 18.50 | 16.67 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
9.37 | 11.77 | 13.49 | 15.77 | 17.28 | 24.37 | 23.40 | 21.22 | 18.50 | 16.67 |
Free Cash Flow |
111.95 | 133.99 | 190.61 | 188.40 | 217.72 | 251.69 | 572.81 | 266.78 | 239.53 | 233.83 |
Working Capital |
175.84 | 208.88 | 174.90 | 182.39 | 110.78 | 379.68 | 235.71 | 185.56 | 49.13 | (32.24) |
Capital Expenditures |
(21.96) | (26.53) | (36.39) | (36.46) | (39.10) | (53.66) | (80.92) | (105.39) | (80.89) | (35.63) |
Net Current Asset Value |
(286.87) | (217.28) | (371.56) | (634.40) | (1,000.09) | (620.81) | (751.07) | (1,251.45) | (1,114.19) | (906.62) |
EV/EBIT |
11.63 | 12.60 | 15.34 | 19.47 | 27.24 | 13.59 | 8.51 | 12.72 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.03 | 0.01 |
Price to Operating Income |
9.81 | 11.16 | 13.23 | 16.45 | 21.68 | 12.20 | 7.30 | 8.96 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.49 | 0.44 | 0.45 | 0.56 | 0.81 | 0.82 | 0.92 | 0.84 | 2.13 | 1.95 |
Cash ROIC |
13.67% | 14.93% | 17.43% | 13.11% | 12.76% | 11.52% | 29.35% | 12.30% | 13.51% | 16.20% |
Accounts Receivable Turnover |
5.28 | 5.08 | 5.29 | 5.28 | 5.47 | 5.39 | 5.31 | 4.50 | 4.78 | 5.82 |
Accounts Payable Turnover |
10.01 | 10.04 | 10.29 | 9.67 | 9.89 | 9.02 | 7.82 | 6.19 | 7.82 | 11.30 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
39.14 | 35.39 | 37.93 | 38.54 | 38.25 | 58.03 | 49.31 | 49.42 | 32.59 | 30.22 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
360.01 | 391.36 | 403.76 | 420.71 | 437.74 | 739.47 | 986.61 | 842.78 | 624.74 | 469.45 |
Average Payables |
128.17 | 133.92 | 139.96 | 152.87 | 162.01 | 296.57 | 450.85 | 410.15 | 264.08 | 173.14 |
Average Assets |
1,033.66 | 1,220.42 | 1,373.34 | 1,712.18 | 2,142.58 | 2,742.71 | 3,010.13 | 2,906.37 | 2,670.06 | 2,254.92 |
Average Common Equity |
398.62 | 505.96 | 600.76 | 687.87 | 778.21 | 990.85 | 1,102.83 | 937.45 | 768.94 | 674.36 |
Columns are period end dates